| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/07/2006 | US20060275317 Vaccine compositions for prevention of chronic and infectious diseases |
| 12/07/2006 | US20060275316 Modulation of cxcr4 and related methods and compositions |
| 12/07/2006 | US20060275315 Nucleic acids and proteins from streptococcus groups a & b |
| 12/07/2006 | US20060275314 Transmembrane protein differentially expressed in cancer |
| 12/07/2006 | US20060275313 Therapeutic and diagnostic agents |
| 12/07/2006 | US20060275312 Molecule |
| 12/07/2006 | US20060275311 Administering intravenous immunoglobulin for treatment and/or prophylaxis of mycobacterial infection |
| 12/07/2006 | US20060275310 Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy |
| 12/07/2006 | US20060275309 Peptide oligomers for use as hiv vaccines |
| 12/07/2006 | US20060275308 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
| 12/07/2006 | US20060275307 Antibodies to treat cancer |
| 12/07/2006 | US20060275306 lyophilized mixture of a recombinant humanized HER2 monoclonal antibody, a lyoprotectant, and a buffer; physical and chemical stability and integrity upon lyophilization and storage; breast cancer |
| 12/07/2006 | US20060275305 HERCEPTIN adjuvant therapy |
| 12/07/2006 | US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 12/07/2006 | US20060275303 Modulating angiogenesis using LL-37/HCAP-18 |
| 12/07/2006 | US20060275302 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system |
| 12/07/2006 | US20060275301 Cell death-inducing agent |
| 12/07/2006 | US20060275300 P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof |
| 12/07/2006 | US20060275299 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 12/07/2006 | US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 12/07/2006 | US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
| 12/07/2006 | US20060275296 Produced by hybridomas; antipruritic agents; blocks scratching, dermatitis, or hairloss |
| 12/07/2006 | US20060275295 Activity of THAP-family chemokine-binding domains |
| 12/07/2006 | US20060275294 Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer |
| 12/07/2006 | US20060275293 Splice variant of the human pituitary growth hormone |
| 12/07/2006 | US20060275292 Fully human anti-CD3 monoclonal antibodies |
| 12/07/2006 | US20060275291 Identification of Unique Binding Interactions Between Certain Antibodies and the Human B7.1 and B7.2 Co-Stimulatory Antigens |
| 12/07/2006 | US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 12/07/2006 | US20060275289 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 12/07/2006 | US20060275288 GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof |
| 12/07/2006 | US20060275287 Scroll compressor |
| 12/07/2006 | US20060275286 Monoclonal antibody named KIS-1N produced by the hybridoma cell line; for development of an agent for the diagnosis and prevention/treatment of diseases (cancer, and so forth) associated with the polypeptide |
| 12/07/2006 | US20060275285 Methods of inhibiting a GPCR |
| 12/07/2006 | US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination |
| 12/07/2006 | US20060275283 Fcgamma receptor-binding polypeptide variants and methods related thereto |
| 12/07/2006 | US20060275282 Antibodies and Fc fusion proteins with altered immunogenicity |
| 12/07/2006 | US20060275270 In vitro mucosal tissue equivalent |
| 12/07/2006 | US20060275266 Tripeptide of FcyRIIA |
| 12/07/2006 | US20060275256 Inhibition of pathogenic agents including alpha6beta1 integrin receptor of alpha6beta4 integrin receptor at a surface |
| 12/07/2006 | US20060275254 covalently linked to a drug that is a physiologically active polypeptide through a non-peptide linker; nonimmunogenic; extended serum half-life of a drug while maintaining the in vivo activity |
| 12/07/2006 | US20060275214 Methods of screening for anti-inflammatory drugs and use thereof |
| 12/07/2006 | US20060275212 Treatment and diagnosis of cancer |
| 12/07/2006 | US20060275211 Antibodies and related molecules that bind to 161P2F10B proteins |
| 12/07/2006 | US20060275210 inhibit proliferation of CK-B4 expression; used to diagnose, treat, prevent cancer, to inhibit the progression or metastasis of myeloproliferative and other disorders such as leukemia, T-cell lymphoma, and/or B-cell lymphoma |
| 12/07/2006 | DE102005024836A1 Composition for treatment and prevention of bone tumors and metastases to bone, comprises microorganisms that carry a gene for abnormal bone sialoprotein, inducing an immune response |
| 12/07/2006 | CA2610667A1 Peptide-based influenza vaccine formulation |
| 12/07/2006 | CA2610619A1 Method of determining immune enhancement of virus infectivity using fc receptor-transfected cell lines |
| 12/07/2006 | CA2610234A1 Antibodies directed to cd20 and uses thereof |
| 12/07/2006 | CA2609995A1 Non-injection immunotherapy |
| 12/07/2006 | CA2609915A1 Modulation of t cell recruitment |
| 12/07/2006 | CA2609600A1 Tweak binding antibodies |
| 12/07/2006 | CA2609554A1 Polyclonal antiserum against a universal tumor antigen |
| 12/07/2006 | CA2609552A1 Molecular glue |
| 12/07/2006 | CA2609262A1 Anti-cd14 antibody fusion protein |
| 12/07/2006 | CA2609244A1 Vaccine compositions and methods for the treatment of urinary incontinence |
| 12/07/2006 | CA2609234A1 Anti-il2 antibodies |
| 12/07/2006 | CA2607699A1 Methods of treating brain tumors with antibodies |
| 12/07/2006 | CA2599322A1 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 12/06/2006 | EP1728865A1 Treatment of cervical cancer |
| 12/06/2006 | EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
| 12/06/2006 | EP1728863A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 12/06/2006 | EP1728802A2 ErbB3 antibodies |
| 12/06/2006 | EP1728801A1 Subtype of humanized antibody against interleukin-6 receptor |
| 12/06/2006 | EP1728800A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 12/06/2006 | EP1728518A1 Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 12/06/2006 | EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2006 | EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 12/06/2006 | EP1727832A2 Antigen of the pm-2 antibody and use thereof |
| 12/06/2006 | EP1727828A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
| 12/06/2006 | EP1727564A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
| 12/06/2006 | EP1727563A1 Method for amplifying therapeutic vaccine activity |
| 12/06/2006 | EP1727562A1 Method of vaccination against testicular bvdv infection |
| 12/06/2006 | EP1727423A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 12/06/2006 | EP1638598B1 ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS |
| 12/06/2006 | EP1353688B1 Method and compositions for immunization with the pseudomonas v antigen |
| 12/06/2006 | EP1166797B1 Method for quality control of an attenuated varicella live vaccine |
| 12/06/2006 | EP1165078B1 Methods of inducing cancer cell death and tumor regression |
| 12/06/2006 | EP1054971B1 Group b streptococcus antigens |
| 12/06/2006 | EP1007686B1 Tuberculosis vaccine |
| 12/06/2006 | EP0956042B1 Mycosis vaccines |
| 12/06/2006 | EP0910406B1 Recombinant canine herpesviruses |
| 12/06/2006 | EP0837934B1 Human vascular endothelial growth factor 2 |
| 12/06/2006 | EP0812333B1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 12/06/2006 | CN1875101A Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpolulations and in cryopreservation, culture and transplantation of cells |
| 12/06/2006 | CN1875030A Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases |
| 12/06/2006 | CN1874790A Therapeutic agent for mesothelioma |
| 12/06/2006 | CN1874788A Cd20结合分子 Cd20 binding molecules |
| 12/06/2006 | CN1874787A Composition for the prophylaxis/treatment of HBV infections and HBV-mediated diseases |
| 12/06/2006 | CN1874786A Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| 12/06/2006 | CN1874785A Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 12/06/2006 | CN1874784A Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections |
| 12/06/2006 | CN1874782A RAGE-related methods and compositions for treating glomerular injury |
| 12/06/2006 | CN1873003A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 12/06/2006 | CN1873002A 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 12/06/2006 | CN1872994A 感染性克隆 Infectious clone |
| 12/06/2006 | CN1872874A Method for preparing capsid protein ú¿VPú®of enteric cytopathogenic human orphan virus 30 |
| 12/06/2006 | CN1872346A Vaccine for diabetes in type I, and constructing method |
| 12/06/2006 | CN1872338A Chewing tablet for discharging lead, and preparation method |
| 12/06/2006 | CN1872028A Immune magnetic Nano microsphere, preparation method, and application |
| 12/06/2006 | CN1288166C Modified tumor antigen peptide and use thereof |